ArticleRSC advances2026
Biocompatible protein-nanomaterial scaffolds for controlled drug delivery.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a series of collagen-hydroxyapatite (Col-HAp) composite scaffolds in the presence and absence of hexagonal boron nitride (h-BN) were fabricated using a controlled lyophilization technique to fabricate a functional biomaterial for drug delivery application. The lyophilization technique creates an interconnected porous network. The incorporation of h-BN in the Col-HAp/h-BN (1 : 2 : 1) scaffold prominently improved the mechanical strength of the scaffold, reaching 10.27 MPa as compared to the non-loaded h-BN scaffold, thereby enhancing its durability and structural stability. The loading of h-BN also displays a significant increase in surface area (47.27 m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.